Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2) — Stella

Recruiting

Back to Retinopathy of Prematurity trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

Duke University Eye Center, Durham, North Carolina

University of Pennsylvania, Center for Preventive Ophthalmology and Biostatistics, Philadelphia, Pennsylvania

Key details

Sponsor

Duke University

Collaborators

University of Pennsylvania, National Eye Institute (NEI)

Enrollment target

~236 participants

Started

August 2021

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov